Valuation: Getinge AB

Market Cap 68.07B 6.82B 6.06B 5.67B 5.14B 9.7B 658B 9.77B 26.47B 335B 25.61B 25.06B 1,079B P/E 2026 *
21.7x
P/E 2027 * 19.3x
Enterprise Value 76.18B 7.63B 6.78B 6.34B 5.75B 10.86B 736B 10.94B 29.63B 375B 28.66B 28.04B 1,207B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.97x
Free-Float
79.13%
Yield 2026 *
2.08%
Yield 2027 * 2.26%
1 day+2.35%
1 week+0.36%
Current month+1.60%
1 month+1.89%
3 months+18.12%
6 months+25.16%
Current year+10.99%
1 week 21.67
Extreme 21.67
22.16
1 month 20.71
Extreme 20.71
22.16
Current year 16.36
Extreme 16.355
22.18
1 year 16.36
Extreme 16.355
22.18
3 years 14.23
Extreme 14.23
22.18
5 years 14.23
Extreme 14.23
42.95
10 years 7.17
Extreme 7.168
42.95
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+2.35%+0.36% - - 6.78B
-1.98%-2.66%-26.53%+1.42% 173B
-1.44%-0.37%-11.85%+13.99% 113B
-2.76%+0.11%-23.81%+4.97% 109B
+1.52%+1.45%-46.87%-10.58% 74.44B
-0.27%+2.15%+2.92%+70.90% 60.1B
+3.27%+7.25%+18.14%+67.16% 51.87B
-0.02%-0.59%-5.78%-31.07% 49.21B
-2.16%-3.65%-18.13%+15.24% 41.52B
-4.45%-3.72%+25.71%+0.24% 32.79B
Average -0.61%+0.62%-9.58%+14.70% 78.34B
Weighted average by Cap. -1.08%+0.42%-15.74%+11.96%

Financials

2026 *2027 *
Net sales 35.35B 3.54B 3.15B 2.94B 2.67B 5.04B 342B 5.08B 13.75B 174B 13.3B 13.02B 560B 37.54B 3.76B 3.34B 3.13B 2.83B 5.35B 363B 5.39B 14.6B 185B 14.12B 13.82B 595B
Net income 3.15B 315M 280M 262M 237M 449M 30.41B 452M 1.22B 15.51B 1.18B 1.16B 49.87B 3.56B 357M 317M 296M 269M 507M 34.39B 511M 1.38B 17.54B 1.34B 1.31B 56.4B
Net Debt 8.11B 813M 722M 675M 612M 1.16B 78.36B 1.16B 3.15B 39.98B 3.05B 2.99B 129B 6.08B 609M 541M 506M 459M 866M 58.72B 872M 2.36B 29.96B 2.29B 2.24B 96.3B
Projected Income Statement - Annual - Getinge AB
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change
06/10/26 €22.16 +2.26%
05/10/26 €21.67 -0.78%
02/10/26 €21.84 +0.51%
01/10/26 €21.73 -0.37%
30/09/26 €21.81 -1.22%
Trader
Investor
Global
Quality
ESG MSCI
B
Ratings Surperformance© - Getinge AB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
249.90SEK
Average target price
252.20SEK
Spread / Average Target
+0.92%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Getinge AB